Matches in Wikidata for { <http://www.wikidata.org/entity/Q66046253> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q66046253 description "clinical trial" @default.
- Q66046253 description "ensayu clínicu" @default.
- Q66046253 description "klinisch onderzoek" @default.
- Q66046253 description "клінічне випробування" @default.
- Q66046253 description "կլինիկական փորձարկում" @default.
- Q66046253 name "Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062)" @default.
- Q66046253 name "Study of Preladenant" @default.
- Q66046253 type Item @default.
- Q66046253 label "Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062)" @default.
- Q66046253 label "Study of Preladenant" @default.
- Q66046253 prefLabel "Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062)" @default.
- Q66046253 prefLabel "Study of Preladenant" @default.
- Q66046253 P1132 Q66046253-A2A5110C-0932-4BD6-A02A-6A2EABD580D2 @default.
- Q66046253 P1476 Q66046253-3DB299C9-3B21-4F74-9ECA-67B0D80AB863 @default.
- Q66046253 P17 Q66046253-1A4E7759-F0F0-43C7-B4F9-FB450AFF55F8 @default.
- Q66046253 P17 Q66046253-51A43A54-016C-4EE6-AF64-04024494DE32 @default.
- Q66046253 P17 Q66046253-5DEA643C-D459-43B7-A6B4-780536F200BE @default.
- Q66046253 P2899 Q66046253-D852B0F4-A7FE-45E2-BD28-B549A68DE15B @default.
- Q66046253 P3098 Q66046253-FA552253-9E87-469E-912F-0752D58AFB6A @default.
- Q66046253 P31 Q66046253-64366429-5747-4128-A922-BA0002E10ADC @default.
- Q66046253 P4844 Q66046253-66FC5D2A-EDF6-4F7E-9631-38995416731B @default.
- Q66046253 P580 Q66046253-ADEBDB86-2FA2-4A0E-925E-8B25398D676D @default.
- Q66046253 P582 Q66046253-BAFD63F6-B68D-4EE1-B51B-2C043220676F @default.
- Q66046253 P6099 Q66046253-FEC42DC7-3E5C-4526-8A1C-CE8202BE8E30 @default.
- Q66046253 P8363 Q66046253-72C2F312-4A25-4BA6-A05B-1EDF6D70E427 @default.
- Q66046253 P1132 "+10" @default.
- Q66046253 P1476 "A Phase Ib/II Study to Evaluate the Safety and Tolerability of Preladenant as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Malignancies" @default.
- Q66046253 P17 Q16 @default.
- Q66046253 P17 Q30 @default.
- Q66046253 P17 Q801 @default.
- Q66046253 P2899 "+18" @default.
- Q66046253 P3098 "NCT03099161" @default.
- Q66046253 P31 Q30612 @default.
- Q66046253 P4844 Q13896859 @default.
- Q66046253 P580 "2017-06-27T00:00:00Z" @default.
- Q66046253 P582 "2017-11-24T00:00:00Z" @default.
- Q66046253 P6099 Q5452194 @default.
- Q66046253 P8363 Q78089383 @default.